Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

Primary Hyperoxaluria Type 1

Phenotyping of Primary Hyperoxaluria BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients Natural History of Patients With PH3 and a History of Stone Events Rare Kidney Stone Consortium Patient Registry Health-related Quality of Life in Rare Kidney Stone Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Patients With Primary Hyperoxaluria Type 1 Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA Phase 2/3 Oxabact Study Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1 A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1 Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria Proteomics of Primary Hyperoxaluria Type 1 Primary Hyperoxaluria Mutation Genotyping/Phenotyping Primary Hyperoxaluria Mutation Genotyping